Portfolio (Quarterly)
Guide ↗
Virtus Investment Advisers, LLC
· CIK 0000019481| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 121 | ORIC | ORIC PHARMACEUTICALS INC | Healthcare | 29,069.0 | $368K | 0.10% | +708.0 | +2.5% | $12.67 | -34.2% |
| 122 | VIR | VIR BIOTECHNOLOGY INC | Healthcare | 40,759.0 | $365K | 0.10% | +995.0 | +2.5% | $8.96 | +1.5% |
| 123 | EWTX | EDGEWISE THERAPEUTICS INC | Healthcare | 11,544.0 | $364K | 0.10% | +281.0 | +2.5% | $31.50 | +8.0% |
| 124 | NCDL | NUVEEN CHURCHILL DIRECT LEND | Financial Services | 28,562.0 | $363K | 0.10% | +1K | +4.0% | $12.72 | +3.5% |
| 125 | XENE | XENON PHARMACEUTICALS INC | Healthcare | 6,188.0 | $360K | 0.10% | +151.0 | +2.5% | $58.15 | -3.7% |
| 126 | NKTR | NEKTAR THERAPEUTICS | Healthcare | 4,984.0 | $359K | 0.10% | +121.0 | +2.5% | $71.95 | +3.3% |
| 127 | PCVX | VAXCYTE INC | Healthcare | 6,126.0 | $356K | 0.10% | +147.0 | +2.5% | $58.11 | -7.9% |
| 128 | PVLA | PALVELLA THERAPEUTICS INC NE | Healthcare | 2,765.0 | $345K | 0.10% | +67.0 | +2.5% | $124.65 | -4.6% |
| 129 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | 18,436.0 | $344K | 0.10% | +449.0 | +2.5% | $18.64 | -1.3% |
| 130 | RLAY | RELAY THERAPEUTICS INC | Healthcare | 33,957.0 | $338K | 0.09% | +827.0 | +2.5% | $9.95 | +28.4% |
| 131 | ANAB | ANAPTYSBIO INC | Healthcare | 6,067.0 | $336K | 0.09% | +148.0 | +2.5% | $55.46 | +13.9% |
| 132 | RVMD | REVOLUTION MEDICINES INC | Healthcare | 3,454.0 | $336K | 0.09% | +83.0 | +2.5% | $97.25 | +53.7% |
| 133 | OFS | OFS CAP CORP | Financial Services | 92,665.0 | $329K | 0.09% | +10K | +12.7% | $3.55 | -1.0% |
| 134 | — | PRAXIS PRECISION MEDICINES I | — | 1,013.0 | $326K | 0.09% | +24.0 | +2.4% | $322.19 | — |
| 135 | CGEM | CULLINAN THERAPEUTICS INC | Healthcare | 22,875.0 | $325K | 0.09% | +557.0 | +2.5% | $14.21 | +10.7% |
| 136 | TERN | TERNS PHARMACEUTICALS INC | Healthcare | 6,058.0 | $319K | 0.09% | +146.0 | +2.5% | $52.72 | +0.4% |
| 137 | PHVS | PHARVARIS N V | Healthcare | 11,286.0 | $319K | 0.09% | +275.0 | +2.5% | $28.25 | +8.7% |
| 138 | CAPR | CAPRICOR THERAPEUTICS INC | Healthcare | 10,479.0 | $319K | 0.09% | +255.0 | +2.5% | $30.40 | -5.3% |
| 139 | CLDX | CELLDEX THERAPEUTICS INC NEW | Healthcare | 9,911.0 | $314K | 0.09% | +240.0 | +2.5% | $31.72 | -1.2% |
| 140 | LQDA | LIQUIDIA CORPORATION | Healthcare | 8,169.0 | $308K | 0.09% | +200.0 | +2.5% | $37.74 | +57.1% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
30.6%
Financial Services
23.4%
Industrials
11.2%
Technology
10.7%
Consumer Cyclical
7.6%
Energy
3.4%
Basic Materials
3.4%
Communication Services
3.1%
Consumer Defensive
2.9%
Real Estate
2.2%